IP Library Granted Patent US 12,617,773
Granted Patent B2
US 12,617,773 · App. 17/997,531 · Granted May 5, 2026

Azetidin-3-ylmethanol derivatives as CCR6 receptor modulators

Inventors: Oliver Allemann (Allschwil, CH); Eva Caroff (Allschwil, CH); Alexia Chavanton-Arpel (Allschwil, CH); Andrew Croxford (Zurich, CH); Francis Hubler (Allschwil, CH); Loïc Jacob (Allschwil, CH); Emmanuel Meyer (Allschwil, CH); Sylvia Richard-Bildstein (Allschwil, CH)
Assignee: IDORSIA PHARMACEUTICALS LTD
C07D401/14A61K31/4427A61K31/4439A61P29/00A61P35/00A61P37/00C07D401/12C07D405/14C07D413/14C07D417/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,617,773
App. No.
17/997,531
Granted
May 5, 2026
Kind
B2
Abstract

The present invention relates to compounds of Formula (I), their synthesis and use as CCR6 receptor modulators for the treatment or prevention of various diseases, conditions or disorders.

Claims (883)

1 . A compound according to Formula (I)

wherein

A represents a 6-membered heteroaryl containing from one to three ring nitrogen atom(s), wherein said 6-membered heteroaryl is unsubstituted, mono-, di- or tri-substituted, wherein the substituent(s), if any, is(are) independently selected from

halogen;

cyano;

hydroxy-C 1-6 -alkyl which is optionally substituted with one to three fluorine atoms;

C 1-5 -alkyl which is unsubstituted or mono-substituted with

C 1-3 -alkoxy;

C 3-6 -cycloalkyl which is optionally fused with a pyridine ring, wherein said C 3-6 -cycloalkyl is unsubstituted or mono-substituted with hydroxy;

—O—R O1 , wherein R O1 represents C 3-6 -cycloalkyl or pyrrolidinyl which is independently unsubstituted or mono-substituted with C 1-3 -alkyl or C 1-4 -alkyl-carbonyl;

phenyl-L 1 -, wherein said phenyl is unsubstituted or mono-substituted with fluorine, C 1-4 -alkoxy-carbonyl, or hydroxy-C 1-4 -alkyl; wherein -L 1 - represents a bond, oxygen, or the group —CH 2 —O—;

C 4-6 -heterocyclyl containing one or two ring heteroatoms independently selected from nitrogen and oxygen, wherein said C 4-6 -heterocyclyl is unsubstituted, mono-, or di-substituted with oxo, hydroxy, C 1-3 -alkyl, C 1-4 -alkyl-carbonyl, or C 1-4 -alkoxy-carbonyl;

5-membered heteroaryl containing one or two ring nitrogen atoms, wherein said 5-membered heteroaryl is unsubstituted or mono-substituted with C 1-3 -alkyl;

indolyl;

pyrrolopyridinyl;

N—(C 1-3 -alkyl)-amino-carbonyl-oxy; or

1-hydroxy-1-C 3-5 -cycloalkyl-1-(pyridinyl)-methyl;

C 3-5 -alkyl which is substituted with hydroxy and R A1 , wherein said substituents are both at position 3 with respect to the point of attachment of said C 3-5 -alkyl to the rest of the molecule; wherein

R A1 represents

tetrahydropyranyl;

phenyl which is unsubstituted or mono-substituted with fluorine or C 1-3 -alkoxy;

5- or 6-membered heteroaryl containing one or two ring heteroatom(s) being independently selected from nitrogen or sulfur, wherein said 5- or 6-membered heteroaryl is independently unsubstituted, mono- or di-substituted, and wherein the substituent(s), if any, is(are) independently selected from C 1-3 -alkyl, C 3-5 -cycloalkyl, or C 1-3 -alkoxy; or

indazolyl;

C 3-5 -alkenyl which is unsubstituted or mono-substituted with hydroxy;

C 4-6 -cycloalkenyl which is unsubstituted, mono-, or di-substituted with C 1-3 -alkyl, oxo, or hydroxy, wherein optionally one ring carbon atom of said C 4-6 -cycloalkenyl is replaced by an oxygen atom;

C 3-6 -cycloalkyl which is unsubstituted, mono-, or di-substituted with C 1-3 -alkyl, hydroxy, or hydroxy-C 1-3 -alkyl, wherein optionally one ring carbon atom of said C 3-6 -cycloalkyl is replaced by an oxygen atom;

—O—RO 2 , wherein

RO 2 represents

C 1-4 -alkyl;

C 2-5 -alkyl which is mono-substituted with hydroxy or C 1-3 -alkoxy;

-L 2 -CY 2 , wherein

 L 2 - independently represents a bond, —CH 2 —, or —CH 2 —CH 2 —; and

 CY 2 independently represents

 phenyl which is unsubstituted or mono-substituted with hydroxy-C 1-3 -alkyl;

 benzyl-oxy;

 5- to 6-membered heteroaryl containing one to three ring heteroatom(s) being independently selected from nitrogen, oxygen, or sulfur, wherein said 5- or 6-membered heteroaryl is independently unsubstituted, mono- or di-substituted; wherein the substituent(s), if any, is(are) independently selected from C 1-3 -alkyl or C 1-3 -cycloalkyl;

 C 3-6 -cycloalkyl, wherein optionally one carbon ring atom is replaced by one heteroatom selected from oxygen and nitrogen; wherein said C 3-6 -cycloalkyl is unsubstituted, mono-, or di-substituted, wherein the substituents are selected from C 1-3 -alkyl, hydroxy, fluoro, oxo, C 1-3 -alkyl-carbonyl and C 1-3 -alkoxy;

 benzooxazolonyl; or

 chromanyl;

—C≡C—R T1 , wherein

R T1 represents

C 1-4 -alkyl, wherein said C 1-4 -alkyl independently is mono-substituted with

 hydroxy;

 C 1-3 -alkoxy;

 -S(═O) 2 —R SOT , wherein R SOT represents C 1-3 -alkyl, C 1-3 -alkyl-amino, or C 3-5 -cycloalkyl;

 -NR NT1 R NT2 wherein R NT1 represents hydrogen and R NT2 represents C 1-3 -alkyl-carbonyl, C 1-3 -alkoxy-C 1-3 -alkyl-carbonyl, or C 3-5 -cycloalkyl-carbonyl;

 C 4-6 -heterocyclyl containing one or two ring heteroatom(s) independently selected from nitrogen and oxygen; wherein said C 4-6 -heterocyclyl is mono-substituted with oxo; or di-substituted with oxo and one C 1-3 -alkyl; or

 N—(C 1-3 -alkyl-carbonyl)-piperidinyl-C 1-3 -alkyl;

C 1-4 -alkyl which is di-substituted, wherein one substituent is hydroxy, and a second substituent is trifluoromethyl;

C 3-6 -cycloalkyl which is mono-substituted with

 hydroxy;

 amino-sulfonyl which is optionally di-substituted with methyl;

 phenyl which is mono-substituted with halogen;

 pyridinyl;

 pyrimidinyl which is mono-substituted with C 1-3 -alkyl; or

 oxazolidinonyl;

C 3-6 -cycloalkyl fused with a pyridine ring, wherein said C 3-6 -cycloalkyl is mono-substituted with hydroxy; wherein optionally one ring carbon atom in said C 3-6 -cycloalkyl is replaced by one oxygen atom;

C 4-6 -heterocyclyl containing one ring heteroatom independently selected from nitrogen and oxygen; wherein said C 4-6 -heterocyclyl is mono-, di-, or tri-substituted, wherein the substituent(s) is(are) independently selected from C 1-3 -alkyl, hydroxy, oxo, C 1-3 -alkyl-carbonyl, C 1-3 -alkoxy-carbonyl, C 1-3 -alkyl-sulfonyl, and C 1-3 -alkyl-amino-sulfonyl;

pyrazolyl which is N-substituted with methyl;

indolyl;

3-hydroxy-1-methyl-1,3-dihydro-indol-2-on-3-yl; or

4-hydroxy-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-yl;

—C≡C—C(OH)(R T2 )(R T3 ), wherein

R T2 represents hydrogen or C 1-3 -alkyl;

R T3 represents

phenyl which is unsubstituted or mono-substituted, wherein the substituent, if any, is selected from C 1-3 -alkoxy and halogen;

5- to 6-membered heteroaryl containing one or two ring heteroatom(s) being independently selected from nitrogen, oxygen, or sulfur; wherein said 5- or 6-membered heteroaryl is independently unsubstituted, mono- or di-substituted, and wherein the substituent(s), if any, is(are) independently selected from C 1-3 -alkyl, C 1-3 -cycloalkyl, C 1-3 -fluoroalkyl, and C 1-3 -alkoxy;

C 4-7 -heterocyclyl containing one ring heteroatom selected from nitrogen and oxygen; wherein said C 4-7 -heterocyclyl is unsubstituted, mono-, or di-substituted, wherein the substituent(s), if any, is(are) independently selected from C 1-3 -alkyl or C 1-3 -alkyl-carbonyl; or

indazolyl;

—NR N3 R N4 wherein

R N3 represents C 1-3 -alkyl; and

R N4 represents hydroxy-C 1-3 -alkyl or 2-(benzyl-oxy)-C 1-3 -alkyl; or

R N3 and R N4 form, together with the nitrogen to which they are attached, a heterocyclic ring of 4 to 6 members, wherein the members needed to complete said heterocyclic ring are each independently selected from —CH 2 —, —O—, —(C=O)—, —CHR X — and —C(R Y ) 2 —; wherein said heterocyclic ring does not contain more than one member independently selected from the group consisting of —O— and —(C=O)—; wherein said heterocyclic ring does not contain more than two members selected from the group consisting of —CHR X —; and wherein said heterocyclic ring does not contain more than two members selected from the group consisting of —C(R Y ) 2 —; wherein R X independently represents fluorine, methyl, isopropyl, isobutyl, tert-butyl, hydroxy, trifluoromethyl, hydroxy-methyl, 1-hydroxy-ethyl, 1-hydroxy-1-methyl-ethyl, cyclopropyl, 2-methoxy-ethyl, 2-methyl-thiazol-5-yl, 4-methyl-thiazol-2-yl, phenyl, benzyl, tetrahydropyran-4-yl, N-acetyl-piperidin-4-yl, 1,2,4-oxadiazolyl, 3-methyl-1,2,4-oxadiazol-5-yl, 2-methyl-2H-[1,2,3]triazol-4-yl, 1-methyl-1H-pyrazol-4-yl, 1-difluoromethyl-1H-pyrazol-4-yl, 1,3-dimethyl-1H-pyrazol-4-yl, pyridin-2-yl, 6-methyl-pyridin-3-yl, 6-isopropyl-pyridin-2-yl, 6-trifluoromethyl-pyridin-3-yl, 2-isopropyl-pyrimidin-4-yl, or 1-methoxy-methyl; and wherein R Y independently represents fluorine, hydroxy, cyclopropyl, methyl, hydroxy-methyl, or trifluoromethyl;

—(C=O)—N(R N5 )(R N6 ), wherein

R N5 represents hydrogen; and

R N6 represents C 3-6 -cycloalkyl or tetrahydropyranyl; or

R N5 and R N6 form, together with the nitrogen to which they are attached, pyrrolidinyl;

piperidin-4-yl or pyrrolidin-3-yl which are mono-substituted at the nitrogen ring atom, wherein the substituent independently is selected from C 1-4 -alkoxy-carbonyl, pyridinyl, phenyl, and 4-methylphenyl-sulfonyl;

5- or 6-membered heteroaryl containing from one to three ring heteroatom(s) independently selected from nitrogen, oxygen and sulfur; wherein said 5- or 6-membered heteroaryl is independently unsubstituted, mono-, di-, or tri-substituted, wherein the substituent(s), if any, is(are) independently selected from

C 1-4 -alkyl which is

unsubstituted;

mono-substituted with

 hydroxy;

 C 1-4 -alkoxy; or

 -N(R N7 )(R N8 ), wherein R N7 represents hydrogen or C 1-3 -alkyl; and R N8 independently represent C 3-5 -cycloalkyl-carbonyl, C 1-3 -alkyl, C 1-3 -alkyl-carbonyl including deuterated C 1-3 -alkyl-carbonyl, C 1-3 -alkoxy-C 1-3 -alkyl-carbonyl, tetrahydropyranyl-carbonyl, or hydroxy-C 1-3 -alkyl-carbonyl;

di-substituted, wherein one substituent is hydroxy, and another substituent is trifluoromethyl; or two substituents are hydroxy; or

di- or tri-substituted, wherein two substituents are fluorine and, if present, one substituent is hydroxy;

-L 3 -CY 3 , wherein

-L 3 - independently represents a bond, —CH 2 —, —CH 2 —CH 2 —, —C(CH 3 ) 2 —, —CH(OH)—, or —O—CH 2 —, wherein when -L 3 - is —O—CH 2 —, said CY 3 is attached to the oxygen atom of said —O—CH 2 —; and

CY 3 independently represents C 4-6 -heterocyclyl, said C 4-6 -heterocyclyl containing one or two ring heteroatoms independently selected from nitrogen and oxygen; wherein said CY 3 independently is unsubstituted, mono-, di-, or tri-substituted, wherein the substituents are independently selected from

 halogen;

 oxo;

 hydroxy;

 C 1-3 -alkyl which is optionally mono-substituted with C 1-3 -alkoxy;

 C 1-3 -alkoxy;

 -(C=O)—R CO , wherein R CO represents

 C 1-3 -alkyl which is optionally mono-substituted with hydroxy or C 1-3 -alkoxy;

 C 1-3 -fluoroalkyl;

 C 1-3 -alkoxy, wherein said C 1-3 -alkoxy is optionally mono-substituted with C 1-3 -alkoxy;

 C 3-6 -cycloalkyl-(CH 2 )n-, wherein optionally one or two carbon ring atom(s) is/are replaced by one or two oxygen ring atom(s); wherein n represents the integer 0, 1, or 2; or

 phenyl;

 -N(R N9 )(R N10 ), wherein R N9 represents hydrogen or C 1-3 -alkyl; and R N10 represents C 1-3 -alkyl, C 1-3 -alkyl-carbonyl, C 1-3 -alkyl-sulfonyl, C 1-3 -alkoxy-carbonyl, C 1-3 -alkoxy-C 1-3 -alkyl-carbonyl, or tetrahydropyranyl-carbonyl;

 -S(═O) 2 —R SO , wherein R SO represents

 C 1-3 -alkyl which is optionally mono-substituted with hydroxy, C 1-3 -alkoxy, or amino; or

 C 3-5 -cycloalkyl, wherein optionally one carbon ring atom is replaced by one oxygen ring atom;

 5-membered heteroaryl containing one ring heteroatom selected from nitrogen, oxygen, and sulfur; wherein said 5-membered heteroaryl is unsubstituted; and

 phenyl-(CH 2 ) p —, wherein p represents the integer 0, 1, or 2;

phenyl or 6-membered heteroaryl containing one or two ring nitrogen atom(s); wherein said phenyl or 6-membered heteroaryl is independently unsubstituted or mono-substituted with C 1-3 -alkyl or C 1-3 -alkoxy;

pyrazolyl-C 1-3 -alkyl;

C 1-3 -alkyl-sulfonyl-C 1-3 -alkyl;

3-hydroxymethyl-bicyclo[1.1.1]pent-1-yl;

7-oxa-bicyclo[2.2.1]hept-2-yl; and

6-oxa-spiro[2.5]oct-1-yl;

5-oxo-4-oxa-6-azaspiro[2.4]hept-6-yl, 5-aza-spiro[2.4]heptan-6-on-5yl, 2,2-dimethyl-6-oxo-5-oxa-7-azaspiro[3.4]oct-7-yl, 2-cyclopropyl-6-oxo-5-oxa-7-azaspiro[3.4]oct-7-yl, 2-oxo-1-oxa-3-azaspiro[4.4]non-3-yl, 8,8-difluoro-2-oxo-1-oxa-3-azaspiro[4.5]dec-3-yl, or 8-oxo-7-oxa-9-azadispiro[3.1.4.1]undec-9-yl;

7-aza-bicyclo[2.2.1]hept-7-yl, 2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl, 6-oxa-3-aza-bicyclo[3.1.1]hept-3-yl, or 8-oxa-3-azabicyclo[3.2.1]oct-3-yl;

5-oxo-6-azaspiro[3.4]oct-6-yl, 3-oxo-2-azaspiro[4.4]non-2-yl, 1-oxa-3-aza-spiro[4.5]decan-2-on-3-yl, 1-oxo-2-azaspiro[4.5]dec-2-yl, 1-oxo-8-oxa-2-azaspiro[4.5]dec-2-yl, 3-oxo-8-oxa-2-azaspiro[4.5]dec-2-yl, or 4-oxo-hexahydro-5H-furo[2,3-c]pyrrol-5-yl;

3-(7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-7-yl)propyl or 3-(8-hydroxy-5,6,7,8-tetrahydroquinolin-8-yl)propyl);

6-acetyl-5,6,7,8-tetrahydro-1,6-naphthyridine-2-yl;

2-(6,7-dihydro-5H-[1]pyrindin-7-ol)-ethyl;

2-(8-hydroxy-5,6,7,8-tetrahydro-quinolin-8-yl)-ethyl;

2,3-dihydro-isoindol-1-on-2-yl; and

6-acetyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-2-yl;

B represents phenyl, which is unsubstituted, mono-, di- or tri-substituted, wherein a first substituent, if present, is selected from

halogen;

C 1-5 -alkyl;

C 2-4 -alkenyl;

C 1-3 -alkoxy;

C 1-3 -alkoxy-C 1-4 -alkyl;

C 1-4 -fluoroalkyl;

C 3-5 -cycloalkyl which independently is unsubstituted or mono-substituted with C 1-3 -alkyl or C 1-3 -fluoroalkyl;

—SF 5 ;

bicyclo[1.1.1]pent-1-yl;

C 3-5 -cycloalkoxy; and

C 1-3 -fluoroalkoxy;

and the remaining substituent/s of B, if present, independently is/are selected from halogen and C 1-3 -alkyl;

or B represents benzothiophenyl or naphthalenyl;

R 1 represents C 1-3 -alkyl, cyano, or halogen; and

R 2 represents C 1-4 -alkyl, C 3-5 -cycloalkyl, C 3-5 -cycloalkyl-C 1-3 -alkyl, hydroxy-C 1-3 -alkyl, C 1-3 -alkoxy-C 1-3 -alkyl, or C 1-3 -fluoroalkyl;

or a pharmaceutically acceptable salt thereof.

2 . A compound according to claim 1 , wherein A represents pyridin-3-yl, wherein A is mono-substituted in meta-position of A with respect to the point of attachment of A to the rest of the molecule, wherein the substituent is as defined in claim 1 ; or a pharmaceutically acceptable salt thereof.

3 . A compound according to claim 1 , wherein said substituent of A or at least one of said substituents of A is 5- or 6-membered heteroaryl as defined in claim 1 , wherein the substituent(s) of said 5- or 6-membered heteroaryl, if any, is(are) independently selected from the optionally substituted C 1-4 -alkyl as defined in claim 1 ; or a pharmaceutically acceptable salt thereof.

4 . A compound according to claim 3 , wherein said substituent of A or at least one of said substituents of A is

5- or 6-membered heteroaryl containing from one to three ring heteroatom(s) independently selected from nitrogen, oxygen and sulfur; wherein said 5- or 6-membered heteroaryl is independently unsubstituted, mono-, di-, or tri-substituted, wherein the substituent(s), if any, is(are) independently selected from

C 1-4 -alkyl which is

unsubstituted;

mono-substituted with

hydroxy; or

C 1-4 -alkoxy;

di-substituted, wherein one substituent is hydroxy, and another substituent is trifluoromethyl; or two substituents are hydroxy; or

di- or tri-substituted, wherein two substituents are fluorine and, if present, one substituent is hydroxy;

or a pharmaceutically acceptable salt thereof.

5 . A compound according to claim 3 , wherein said substituent of A or at least one of said substituents of A is 1,2,4-oxadiazol-5-yl or 1,2,4-oxadiazol-3-yl, wherein said oxadiazolyl groups are mono-substituted, wherein the substituent is independently selected from C 1-4 -alkyl which is mono-substituted with hydroxy or C 1-4 -alkoxy;

or a pharmaceutically acceptable salt thereof.

6 . A compound according to claim 1 , wherein B represents phenyl, which is mono-, di- or tri-substituted, wherein a first substituent is attached in para-position with respect to the point of attachment of B to the rest of molecule, wherein said substituent is selected from

C 1-5 -alkyl;

C 1-3 -alkoxy-C 1-4 -alkyl;

C 1-2 -fluoroalkyl;

C 3-5 -cycloalkyl which is unsubstituted or mono-substituted with C 1-3 -alkyl or C 1-3 -fluoroalkyl; and

C 1 -fluoroalkoxy;

and the remaining substituent(s) of B, if present, independently is/are selected from halogen;

or a pharmaceutically acceptable salt thereof.

7 . A compound according to claim 1 , wherein R 1 represents methyl; or a pharmaceutically acceptable salt thereof.

8 . A compound according to claim 1 , wherein R 2 represents C 1-4 -alkyl, C 3-5 -cycloalkyl, C 3-5 -cycloalkyl-C 1-3 -alkyl, or C 1-3 -fluoroalkyl; or a pharmaceutically acceptable salt thereof.

9 . A compound according to claim 1 , which is also a compound of Formula (II)

or a pharmaceutically acceptable salt thereof.

10 . A compound according to claim 1 which is:

(3-Fluoro-1-methyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

3-[Hydroxy-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methyl]-1-methyl-azetidine-3-carbonitrile;

(R)-(1-Ethyl-3-methyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(R)-(3-Methyl-1-propyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(R)-(1-Isopropyl-3-methyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(R)-(1-Cyclopropylmethyl-3-methyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(R)-(1-Cyclobutyl-3-methyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(R)-(1-Isobutyl-3-methyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(R)-(1-Cyclopropyl-3-methyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(R)-[1-(2-Fluoro-ethyl)-3-methyl-azetidin-3-yl]-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(R)-[1-(2,2-Difluoro-ethyl)-3-methyl-azetidin-3-yl]-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(R)-(1-tert-Butyl-3-methyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(3-methoxy-prop-1-ynyl)-pyridin-3-yl]-methanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-prop-1-yn-1-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-methyl-but-3-yn-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-but-3-yn-2-ol;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-but-3-yn-2-ol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-cyclopentanol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-cyclopropanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-3-hydroxy-azetidine-1-carboxylic acid tert-butyl ester;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-cyclobutanol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-but-3-yn-1-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(1-methyl-1H-pyrazol-4-ylethynyl)-pyridin-3-yl]-methanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-phenyl-prop-2-yn-1-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-phenyl-but-3-yn-2-ol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-methyl-pent-1-yn-3-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-tetrahydro-pyran-4-ol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-(tetrahydro-pyran-4-yl)-prop-2-yn-1-ol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-(1,3-dimethyl-1H-pyrazol-4-yl)-prop-2-yn-1-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(tetrahydro-pyran-4-ylethynyl)-pyridin-3-yl]-methanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-(2-methyl-thiazol-4-yl)-prop-2-yn-1-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(3-fluoro-phenyl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(4-methoxy-phenyl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methoxy-phenyl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1-methyl-1H-pyrazol-3-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methyl-thiazol-4-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methoxy-pyridin-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-pyrimidin-2-yl-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1,5-dimethyl-1H-pyrazol-3-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyrimidin-4-yl)-but-3-yn-2-ol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-(1,5-dimethyl-1H-pyrazol-3-yl)-prop-2-yn-1-ol;

8-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-5,6,7,8-tetrahydro-quinolin-8-ol;

7-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-6,7-dihydro-5H-[1]pyrindin-7-ol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-pyridin-2-yl-pent-1-yn-3-ol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-(6-methoxy-pyridin-2-yl)-pent-1-yn-3-ol;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-3-hydroxy-azetidin-1-yl)-2-methyl-propan-1-one;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-(1H-indol-2-ylethynyl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(3-methoxy-propyl)-pyridin-3-yl]-methanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-propan-1-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-methyl-butan-2-ol;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-butan-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-butan-2-ol;

1-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-cyclopentanol;

1-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-cyclopropanol;

3-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-3-hydroxy-azetidine-1-carboxylic acid tert-butyl ester;

1-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-cyclobutanol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-butan-1-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[2-(1-methyl-1H-pyrazol-4-yl)-ethyl]-pyridin-3-yl}-methanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-phenyl-propan-1-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-phenyl-butan-2-ol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-methyl-pentan-3-ol;

4-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-tetrahydro-pyran-4-ol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-(tetrahydro-pyran-4-yl)-propan-1-ol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-(1,3-dimethyl-1H-pyrazol-4-yl)-propan-1-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[2-(tetrahydro-pyran-4-yl)-ethyl]-pyridin-3-yl}-methanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-(2-methyl-thiazol-4-yl)-propan-1-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(3-fluoro-phenyl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(4-methoxy-phenyl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methoxy-phenyl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1-methyl-1H-pyrazol-3-yl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methyl-thiazol-4-yl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methoxy-pyridin-2-yl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-pyrimidin-2-yl-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1,5-dimethyl-1H-pyrazol-3-yl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyrimidin-4-yl)-butan-2-ol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-(1,5-dimethyl-1H-pyrazol-3-yl)-propan-1-ol;

8-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-5,6,7,8-tetrahydro-quinolin-8-ol;

7-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-6,7-dihydro-5H-[1]pyrindin-7-ol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-pyridin-2-yl-pentan-3-ol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-(6-methoxy-pyridin-2-yl)-pentan-3-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[2-(1H-indol-2-yl)-ethyl]-pyridin-3-yl}-(4-isopropyl-phenyl)-methanol;

(R)-(4-Cyclopropyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-{5-[3-(tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-(4-Cyclopropyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-{5-[3-(2-methoxy-1,1-dimethyl-ethyl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-[5-(3-Cyclobutoxymethyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-(4-cyclopropyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-propyl-phenyl)-{5-[3-(tetrahydro-pyran-4-yloxymethyl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-propyl-phenyl)-{5-[3-(tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-[5-(3-Cyclobutoxymethyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-propyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[3-(tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(3-morpholin-4-ylmethyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[3-(2,6-dimethyl-morpholin-4-ylmethyl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[3-(4-methyl-tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[(1S,2S,4R)-3-(7-oxa-bicyclo[2.2.1]hept-2-yl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[3-(tetrahydro-pyran-4-yloxymethyl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(3-morpholin-4-yl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-methanol;

(R)-(4-Cyclopropyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-{5-[3-(4-methoxy-tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-(4-Cyclopropyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-{5-[3-(3-hydroxymethyl-bicyclo[1.1.1]pent-1-yl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[3-(3-hydroxymethyl-bicyclo[1.1.1]pent-1-yl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-(4-isopropyl-phenyl)-methanol;

2-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-yl)-2-methyl-propan-1-ol;

2-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-yl)-propan-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[3-(1-methoxy-1-methyl-ethyl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[3-(1-methoxy-cyclobutyl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

1-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-yl)-2-methyl-propan-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(5-methanesulfonylmethyl-[1,2,4]oxadiazol-3-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(2-methoxy-ethyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(5-methoxymethyl-[1,2,4]oxadiazol-3-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(tetrahydro-furan-3-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-cyclohexanol;

(R)-[5-(5-tert-Butoxymethyl-[1,2,4]oxadiazol-3-yl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(tetrahydro-pyran-4-ylmethyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-cyclohexanol;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-cyclohexanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(1-methoxy-cyclobutyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(6-oxa-spiro[2.5]oct-1-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(tetrahydro-pyran-3-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-{5-[1-(tetrahydro-furan-2-yl)methyl]-[1,2,4]oxadiazol-3-yl}-pyridin-3-yl)-methanol;

(R)-2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1,1,1-trifluoro-propan-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(1-methoxy-1-methyl-ethyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-{5-[5-((R)-Cyclohexyl-hydroxy-methyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-cyclopropanol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-cyclopentanol;

3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-cyclobutanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[5-(4-fluoro-tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[5-((2R,4R,6S)-2,6-dimethyl-tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(tetrahydro-pyran-4-yloxymethyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-{5-[1-methyl-1-(tetrahydro-pyran-4-yl)-ethyl]-[1,2,4]oxadiazol-3-yl}-pyridin-3-yl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-{5-[2-(tetrahydro-pyran-4-yl)-ethyl]-[1,2,4]oxadiazol-3-yl}-pyridin-3-yl)-methanol;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-cyclobutanol;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-2-methyl-propan-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(7-oxa-bicyclo[2.2.1]hept-2-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(4-methyl-tetrahydro-pyran-4-yloxymethyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(5-oxetan-3-yl-[1,2,4]oxadiazol-3-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(2-methoxy-1,1-dimethyl-ethyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-2-methyl-propan-1-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(2-methoxy-2-methyl-propyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-cyclobutanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(1-methoxymethyl-cyclopropylmethyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(2-pyrazol-1-yl-ethyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)—N-(2-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)ethyl)acetamide-2,2,2-d 3 ;

(R)—N-(1-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)-2-methylpropan-2-yl)acetamide-2,2,2-d 3 ;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-2-hydroxy-ethanone;

(R)-1-(4-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)ethan-1-one-2,2,2-d 3 ;

N-[2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-ethyl]-2-hydroxy-N-methyl-acetamide;

(R)—N-(2-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)ethyl)-N-methylacetamide-d 3 ;

(1,3-Dimethyl-azetidin-3-yl)-(6-methoxy-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(6-phenoxy-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(6-ethoxy-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(5-methyl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-propyl-phenyl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-methoxy-phenyl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-ethyl-phenyl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-phenyl-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(4-Cyclobutyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(4-Cyclobutoxy-phenyl)-(1,3-dimethyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-ethoxy-phenyl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(4-tert-Butyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropoxy-phenyl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-methanol;

(1,3-Dimethyl-azetidin-3-yl)-[4-(1-methyl-cyclopropyl)-phenyl]-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(4-Cyclopropoxy-phenyl)-(1,3-dimethyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(S)-[2-(3,3-Difluoro-pyrrolidin-1-yl)-pyridin-4-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(S)-[2-((3R,4S)-3,4-Difluoro-pyrrolidin-1-yl)-pyridin-4-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(S)-(1,3-Dimethyl-azetidin-3-yl)-(2-isobutoxy-pyridin-4-yl)-(4-isopropyl-phenyl)-methanol;

4-{4-[(S)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-2-yl}-2-methyl-butan-2-ol;

(R)-[6-(3,3-Difluoro-pyrrolidin-1-yl)-pyridazin-4-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(S)-5-tert-Butyl-3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-oxazolidin-2-one;

(R)-1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrrolidin-3-ol;

(S)-1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrrolidin-3-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-((S)-3-hydroxymethyl-pyrrolidin-1-yl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(S)-1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-methyl-pyrrolidin-3-ol;

3-Cyclopropyl-1-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrrolidin-3-ol;

2-((S)-1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrrolidin-3-yl)-propan-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-morpholin-4-yl-pyridin-3-yl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(3,4,5,6-tetrahydro-2H-[1,3′]bipyridinyl-5′-yl)-methanol;

(R)-[5-(7-Aza-bicyclo[2.2.1]hept-7-yl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-((S)-2-methyl-pyrrolidin-1-yl)-pyridin-3-yl]-methanol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-trifluoromethyl-pyrrolidin-3-ol;

(R)-[5-(3,3-Difluoro-pyrrolidin-1-yl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

5′-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-3,4,5,6-tetrahydro-2H-[1,3′]bipyridinyl-4-ol;

5′-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-3,4,5,6-tetrahydro-2H-[1,3′]bipyridinyl-3-ol;

(R)-{5-[(2-Benzyloxy-ethyl)-methyl-amino]-pyridin-3-yl}-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[4-(1-methyl-cyclopropyl)-phenyl]-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(R)-[5-((3R,4S)-3,4-Difluoro-pyrrolidin-1-yl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-methanol;

2-[(S)-1-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-methyl}-pyridin-3-yl)-pyrrolidin-3-yl]-propan-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-methanol;

(R)-(4-tert-Butyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-(3,4,5,6-tetrahydro-2H-[1,3′]bipyridinyl-5′-yl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(R)-{5-[5-(1-Cyclopropanesulfonyl-piperidin-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

2-({5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-methyl-amino)-ethanol;

(R)-1-((S)-1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrrolidin-3-yl)-ethanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-oxazolidin-2-one;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-5-phenyl-oxazolidin-2-one;

5-Benzyl-3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-oxazolidin-2-one;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-5-isopropyl-oxazolidin-2-one;

6-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-oxa-6-aza-spiro[2.4]heptan-5-one;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-oxa-3-aza-spiro[4.4]nonan-2-one;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-5-(tetrahydro-pyran-4-yl)-oxazolidin-2-one;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-5,5-dimethyl-oxazolidin-2-one;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-8,8-difluoro-1-oxa-3-aza-spiro[4.5]decan-2-one;

9-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-7-oxa-9-aza-dispiro[3.1.4.1]undecan-8-one;

2-Cyclopropyl-7-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-5-oxa-7-aza-spiro[3.4]octan-6-one;

7-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2,2-dimethyl-5-oxa-7-aza-spiro[3.4]octan-6-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-phenyl-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-isopropyl-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-isopropyl-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4,4-dimethyl-pyrrolidin-2-one;

5-(5-((R)-(1,3-Dimethyl-azetidin-3-yl)(hydroxy)(4-isopropyl-phenyl)methyl)pyridin-3-yl)hexahydro-4H-furo[2,3-c]pyrrol-4-one;

2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-aza-spiro[4.4]nonan-3-one;

6-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-6-aza-spiro[3.4]octan-5-one;

2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-8-oxa-2-aza-spiro[4.5]decan-3-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-(tetrahydro-pyran-4-yl)-pyrrolidin-2-one;

2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-aza-spiro[4.5]decan-1-one;

2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-8-oxa-2-aza-spiro[4.5]decan-1-one;

(S)-1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-isobutyl-pyrrolidin-2-one;

4-Cyclopropyl-1-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-trifluoromethyl-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-(2-methoxy-ethyl)-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-(2-methoxy-ethyl)-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-pyrrolidin-2-one;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-((R)-3-isopropyl-pyrrolidin-1-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-((2R,6S)-2,6-dimethyl-morpholin-4-yl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(6-oxa-3-aza-bicyclo[3.1.1]hept-3-yl)-pyridin-3-yl]-methanol;

(R)-[5-((3R,4S)-3,4-Difluoro-pyrrolidin-1-yl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-[5-((3S,4S)-3,4-Difluoro-pyrrolidin-1-yl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-((2S,6S)-2,6-dimethyl-morpholin-4-yl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-((2R,6R)-2,6-dimethyl-morpholin-4-yl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[3-(3-methyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[3-(4-methyl-thiazol-2-yl)-pyrrolidin-1-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(3-phenyl-pyrrolidin-1-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-(3,3-dimethyl-pyrrolidin-1-yl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[(1S,4S)-5-(2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(2,2,6,6-tetrafluoro-morpholin-4-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-((R)-2-methoxymethyl-morpholin-4-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-((S)-2-methoxymethyl-morpholin-4-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(3-trifluoromethyl-pyrrolidin-1-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[(1R,4R)-5-(2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[(1S,5R)-5-(8-oxa-3-aza-bicyclo[3.2.1]oct-3-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[(1S,4S)-5-(2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-pyridin-3-yl]-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-ethyl-phenyl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-ethyl-phenyl)-[5-(6-oxa-3-aza-bicyclo[3.1.1]hept-3-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-ethyl-phenyl)-[(1S,4S)-5-(2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-pyridin-3-yl]-methanol;

(R)-(5-Benzyloxy-pyridin-3-yl)-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(2-pyridin-2-yl-ethoxy)-pyridin-3-yl]-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(2-methoxy-ethoxy)-pyridin-3-yl]-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(oxetan-3-ylmethoxy)-pyridin-3-yl]-methanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yloxy}-propan-1-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(5-isopropoxy-pyridin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(5-Cyclohexyloxy-pyridin-3-yl)-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yloxy}-2-methyl-propan-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(3-methoxy-cyclopentyloxy)-pyridin-3-yl]-methanol;

(R)-[5-(3-Cyclopropyl-[1,2,4]oxadiazol-5-ylmethoxy)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[2-(3,5-dimethyl-[1,2,4]triazol-1-yl)-ethoxy]-pyridin-3-yl}-(4-isopropyl-phenyl)-methanol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yloxy}-2-methyl-butan-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-methoxy-pyridin-3-yl)-methanol;

(R)-[5-(2-Benzyloxy-ethoxy)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(tetrahydro-pyran-4-yloxy)-pyridin-3-yl]-methanol;

2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yloxy}-ethanol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yloxy}-cyclohexanol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yloxy}-1-methyl-cyclohexanol;

(1,3-Dimethyl-azetidin-3-yl)-(2-phenoxy-pyrimidin-5-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(6-Benzyloxy-pyridin-3-yl)-(1,3-dimethyl-azetidin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(5-pyrazol-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(6-fluoro-5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethoxy-phenyl)-methanol;

5-[(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-trifluoromethoxy-phenyl)-methyl]-3-pyrrolidin-1-yl-pyridine-2-carbonitrile;

(1,3-Dimethyl-azetidin-3-yl)-[6-(tetrahydro-pyran-4-yloxy)-pyridin-3-yl]-(4-trifluoromethoxy-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-[6-(oxetan-3-ylmethoxy)-pyridin-3-yl]-(4-trifluoromethoxy-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(4-methyl-thiazol-2-yl)-pyridin-3-yl]-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(5-methyl-thiazol-2-yl)-pyridin-3-yl]-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(2-methoxy-pyrimidin-5-yl)-methanol;

(S)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(2-pyrrolidin-1-yl-pyridin-4-yl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-[2-((R)-2-hydroxymethyl-pyrrolidin-1-yl)-pyridin-4-yl]-(4-isopropyl-phenyl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(3,4,5,6-tetrahydro-2H-[1,2′]bipyridinyl-4′-yl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(2-morpholin-4-yl-pyridin-4-yl)-methanol;

(S)-(1,3-Dimethyl-azetidin-3-yl)-(2-ethyl-pyridin-4-yl)-(4-isopropyl-phenyl)-methanol;

(S)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[2-(tetrahydro-pyran-4-ylmethoxy)-pyridin-4-yl]-methanol;

(S)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[2-(2-methoxy-ethoxy)-pyridin-4-yl]-methanol;

(S)-(2-Cyclopentyl-pyridin-4-yl)-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-(4-trifluoromethyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-((R)-3-hydroxymethyl-3-methyl-pyrrolidin-1-yl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-((S)-3-fluoro-pyrrolidin-1-yl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[4-(tetrahydro-pyran-4-yl)-[1,2,3]triazol-1-yl]-pyridin-3-yl}-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-methyl-pyridin-3-yl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(5-isopropenyl-pyridin-3-yl)-(4-isopropyl-phenyl)-methanol;

(5-Cyclopropyl-pyridin-3-yl)-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(5-Cyclopent-1-enyl-pyridin-3-yl)-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

3-{5-[(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-cyclopent-2-enol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-isopropyl-pyridin-3-yl)-methanol;

(5-Cyclopentyl-pyridin-3-yl)-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

3-{5-[(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-cyclopentanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-pyridin-3-yl-methanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-cyclopent-2-enone;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-methyl-cyclopent-2-enol;

(3S)-3-(5-((R)-(1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1-methylcyclopentan-1-ol;

(3R)-3-(5-((R)-(1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1-methylcyclopentan-1-ol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-ethyl-cyclopentanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-isopropyl-cyclopentanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(4-methyl-oxazol-2-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(5-ethyl-pyridin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-methyl-pyridin-3-yl)-methanol;

(R)-[5-(4,5-Dihydro-furan-3-yl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(tetrahydro-furan-3-yl)-pyridin-3-yl]-methanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-but-3-en-1-ol;

N-Cyclopentyl-5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-nicotinamide;

{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrrolidin-1-yl-methanone;

5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-N-(tetrahydro-pyran-4-yl)-nicotinamide;

(1,3-Dimethyl-azetidin-3-yl)-[4-(3-methoxy-propyl)-phenyl]-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(R)-(4-Cyclopropyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(5-pyrrolidin-1-yl-pyridin-3-yl)-p-tolyl-methanol;

5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-3′,4′,5′,6′-tetrahydro-2′H-[3,4′]bipyridinyl-1′-carboxylic acid tert-butyl ester;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrrolidine-1-carboxylic acid tert-butyl ester;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(tetrahydro-pyran-4-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(3′,4′,5′,6′-tetrahydro-2′H-[2,1′;4′,3″ ]terpyridin-5″-yl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(1′-phenyl-1′,2′,3′,4′,5′,6′-hexahydro-[3,4′]bipyridinyl-5-yl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[1′-(toluene-4-sulfonyl)-1′,2′,3′,4′,5′,6′-hexahydro-[3,4′]bipyridinyl-5-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(tetrahydro-furan-2-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(5-methyl-tetrahydro-furan-2-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-(5,5-dimethyl-tetrahydro-furan-2-yl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2,2-difluoro-propan-1-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(5-methyl-oxazol-2-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(tetrahydro-pyran-4-yl)-oxazol-2-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-(4-fluoro-phenoxymethyl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

Isopropyl-carbamic acid 5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylmethyl ester;

(R)-[5-(2-Benzyloxy-ethyl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-methyl-cyclohexanol;

2-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-cyclopropyl)-propan-2-ol;

(S)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{2-[5-(tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-4-yl}-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(2-pyrrolidin-1-yl-pyrimidin-5-yl)-methanol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(6-pyrrolidin-1-yl-pyrazin-2-yl)-methanol;

(R)—N-(1-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)cyclopropyl)acetamide-2,2,2-d 3 ;

(R)—N-(1-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)cyclopropyl)-N-methylacetamide-d 3 ;

(R)—N-((3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)-N-methylacetamide-d 3 ;

N-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-2-hydroxy-acetamide;

(R)—N-((3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)methyl)acetamide-2,2,2-d 3 ;

1-(3-{5-[(R)-Hydroxy-(1-isopropyl-3-methyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-2-methyl-propan-2-ol;

1-(3-{5-[(R)-(1-Ethyl-3-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-2-methyl-propan-2-ol;

2-(3-{5-[(R)-Hydroxy-(1-isopropyl-3-methyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(1-Ethyl-3-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

4-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-yl)-piperidine-1-carboxylic acid benzyl ester;

1-[4-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-yl)-piperidin-1-yl]-ethanone;

(R)-1-(3-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)azetidin-1-yl)ethan-1-one-2,2,2-d 3 ;

(R)-1-(3-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)-3-methylazetidin-1-yl)ethan-1-one-2,2,2-d 3 ;

(R)-1-(3-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-isopropylphenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)-3-fluoroazetidin-1-yl)ethan-1-one-2,2,2-d 3 ;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(1-methyl-1-morpholin-4-yl-ethyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-methyl-piperidin-2-one;

1-[(S)-3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-ethanone;

1-[(R)-3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-ethanone;

N-[1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-methyl-ethyl]-acetamide;

1-Benzyl-3-(3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-pyrrolidin-2-one;

3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1,3-dimethyl-pyrrolidin-2-one;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-isobutyl-pyrrolidin-2-one;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-furan-2-ylmethyl-pyrrolidin-2-one;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-phenyl-pyrrolidin-2-one;

1-Benzyl-4-(3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-pyrrolidin-2-one;

5-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-phenyl-pyrrolidin-2-one;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-pyrrolidin-2-one;

(S)-5-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-pyrrolidin-2-one;

(R)-5-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-pyrrolidin-2-one;

(S)-6-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-2-one;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-2-one;

(S)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-azetidin-2-one;

(S)-3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-azetidin-2-one;

(R)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1,4-dimethyl-pyrrolidin-2-one;

(S)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1,4-dimethyl-pyrrolidin-2-one;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(5-piperidin-4-yl-[1,2,4]oxadiazol-3-yl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(4-methyl-piperidin-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[5-(4-fluoro-piperidin-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-(4-isopropyl-phenyl)-methanol;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-butan-1-one;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-2,2-dimethyl-propan-1-one;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-2-methoxy-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-3-methoxy-propan-1-one;

Cyclopropyl-[4-(3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-methanone;

Cyclopentyl-[4-(3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-methanone;

[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-(tetrahydro-pyran-4-yl)-methanone;

[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-phenyl-methanone;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidine-1-carboxylic acid methyl ester;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidine-1-carboxylic acid ethyl ester;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidine-1-carboxylic acid 2-methoxy-ethyl ester;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(1-methanesulfonyl-piperidin-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-{5-[1-(propane-2-sulfonyl)-piperidin-4-yl]-[1,2,4]oxadiazol-3-yl}-pyridin-3-yl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-{5-[1-(propane-1-sulfonyl)-piperidin-4-yl]-[1,2,4]oxadiazol-3-yl}-pyridin-3-yl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-{5-[1-(2-methoxy-ethanesulfonyl)-piperidin-4-yl]-[1,2,4]oxadiazol-3-yl}-pyridin-3-yl)-methanol;

2-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidine-1-sulfonyl]-ethanol;

(R)-{5-[5-(1-Cyclopentanesulfonyl-piperidin-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-{5-[1-(tetrahydro-pyran-4-sulfonyl)-piperidin-4-yl]-[1,2,4]oxadiazol-3-yl}-pyridin-3-yl)-methanol;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidine-1-sulfonic acid methylamide;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(1-methylamino-cyclopropyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

[1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-cyclopropyl]-methyl-carbamic acid ethyl ester;

N-[1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-cyclopropyl]-N-methyl-methanesulfonamide;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[6-(2,2-dimethyl-cyclopentyloxy)-pyridazin-4-yl]-(4-isopropyl-phenyl)-methanol;

(R)-[6-(3,3-Difluoro-cyclopentyloxy)-pyridazin-4-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

2-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yloxy}-phenyl)-ethanol;

2-(4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yloxy}-phenyl)-ethanol;

(R)-[6-(Chroman-6-yloxy)-pyridazin-4-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

6-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yloxy}-3H-benzooxazol-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-(6-methyl-pyrimidin-4-yl)-pent-1-yn-3-ol;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyrimidin-4-yl)-but-3-yn-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyrimidin-4-yl)-but-3-yn-2-ol;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1,5-dimethyl-1H-pyrazol-3-yl)-but-3-yn-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1,5-dimethyl-1H-pyrazol-3-yl)-but-3-yn-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[1-(4-fluoro-phenyl)-cyclopropylethynyl]-pyridin-3-yl)-(4-isopropyl-phenyl)-methanol;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1-methyl-1H-pyrazol-3-yl)-but-3-yn-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1-methyl-1H-pyrazol-3-yl)-but-3-yn-2-ol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-3-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-piperidine-1-carboxylic acid tert-butyl ester;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-3-(6-methyl-pyrimidin-4-yl)-pentan-3-ol;

2-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-benzoic acid methyl ester;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[2-(2-hydroxymethyl-phenyl)-ethyl]-pyridin-3-yl}-(4-isopropyl-phenyl)-methanol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methoxy-pyrimidin-4-yl)-butan-2-ol;

3-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-3-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[2-(1H-pyrrolo[2,3-b]pyridin-2-yl)-ethyl]-pyridin-3-yl}-methanol;

4-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-piperidine-1-carboxylic acid tert-butyl ester;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-pyridin-2-yl-butan-2-ol;

1-Cyclopropyl-3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-pyridin-2-yl-propan-1-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(5-methyl-pyridin-3-yl)-butan-2-ol;

8-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-ethyl)-5,6,7,8-tetrahydro-quinolin-8-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-2-(6-methoxy-pyridin-2-yl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-2-(6-methyl-pyridin-2-yl)-butan-2-ol;

(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(6-pyrrolidin-1-yl-pyridin-2-yl)-methanol;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-4-fluoro-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-4-methyl-piperidin-1-yl]-ethanone;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yloxy}-cyclohexanone;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-cyclohexanol;

(R)-(5-Cyclopentyloxymethyl-pyridin-3-yl)-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

1-(4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylmethoxy}-piperidin-1-yl)-ethanone;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[6-(tetrahydro-pyran-4-yl)-pyridazin-4-yl]-methanol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-2-phenyl-butan-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{6-[(S)-(tetrahydro-furan-3-yl)oxy]-pyridazin-4-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{6-[(R)-(tetrahydro-furan-3-yl)oxy]-pyridazin-4-yl}-methanol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-4-methyl-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-3-isopropyl-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-3,3-dimethyl-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-4,4-dimethyl-pyrrolidin-2-one;

5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-5-aza-spiro[2.4]heptan-6-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-4-trifluoromethyl-pyrrolidin-2-one;

4-Cyclopropyl-1-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-pyrrolidin-2-one;

2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-8-oxa-2-aza-spiro[4.5]decan-3-one;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-1-oxa-3-aza-spiro[4.5]decan-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-4-pyridin-2-yl-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-3-(2-methoxy-ethyl)-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-4-phenyl-pyrrolidin-2-one;

2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-2,3-dihydro-isoindol-1-one;

2-(3-{5-[(S)-(3-Fluoro-1-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(S)-(1-Cyclopropyl-3-fluoro-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

1-[4-(3-{5-[(S)-(3-Fluoro-1-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(S)-(1-Cyclopropyl-3-fluoro-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

2-(3-{5-[(R)-(1-Cyclopropyl-3-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

1-[4-(3-{5-[(R)-(1-Cyclopropyl-3-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

(R)-(1-Cyclopropyl-3-methyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

trans-4-(3-{5-[(R)-(1-Cyclopropyl-3-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-cyclohexanol;

(R)-(1-Cyclopropyl-3-methyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(5-oxetan-3-yl-[1,2,4]oxadiazol-3-yl)-pyridin-3-yl]-methanol;

1-[(R)-3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-pyrrolidin-1-yl]-ethanone;

1-[3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-[3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-3-hydroxy-piperidin-1-yl]-ethanone;

1-[3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-3-methyl-piperidin-1-yl]-ethanone;

1-[3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-4-hydroxy-piperidin-1-yl]-ethanone;

N-[1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-cyclopropyl]-acetamide;

Tetrahydro-pyran-4-carboxylic acid [1-(3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-cyclopropyl]-amide;

N-[1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-cyclopropyl]-2-methoxy-acetamide;

N-[1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-cyclopropyl]-N-methyl-acetamide;

N-[2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1,1-dimethyl-ethyl]-propionamide;

N-[2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1,1-dimethyl-ethyl]-2-methoxy-acetamide;

Tetrahydro-pyran-4-carboxylic acid [2-(3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1,1-dimethyl-ethyl]-amide;

N-[2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1,1-dimethyl-ethyl]-isobutyramide;

Cyclopropanecarboxylic acid [2-(3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1,1-dimethyl-ethyl]-amide;

1-[cis-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-2-methyl-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-4-hydroxy-piperidin-1-yl]-2-methyl-propan-1-one;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-4-hydroxy-piperidin-1-yl]-propan-1-one;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-4-methoxy-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-3,3,3-trifluoro-propan-1-one;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-2-oxetan-3-yl-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-4-ethyl-piperidin-1-yl]-ethanone;

[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-oxetan-3-yl-methanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-4-isopropyl-piperidin-1-yl]-2-methoxy-ethanone;

1-[cis-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-3-methyl-piperidin-1-yl]-ethanone;

5-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-methyl-piperidin-2-one;

5-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-5-methyl-piperidin-2-one;

5-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-2-one;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-4-methyl-pyrrolidin-2-one;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-3,3-dimethyl-pyrrolidine-2,5-dione;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-imidazolidine-2,4-dione;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-pyrrolidin-2-one;

3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-imidazolidine-2,4-dione;

3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-1-methyl-imidazolidine-2,4-dione;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-3-methyl-imidazolidine-2,4-dione;

3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-oxazolidin-2-one;

1-Cyclopropyl-3-(3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-imidazolidin-2-one;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-pyrrolidine-2,5-dione;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-3-methyl-imidazolidin-2-one;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-imidazolidin-2-one;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propane-1,2-diol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(5-pyridin-3-yl-[1,2,4]oxadiazol-3-yl)-pyridin-3-yl]-methanol;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-piperidin-1-yl]-ethanone;

(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-acetonitrile;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-4-hydroxy-piperidin-1-yl]-ethanone;

3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propionitrile;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-3-methoxy-piperidin-1-yl]-ethanone;

1-[(R)-3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-tetrahydro-pyran-4-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[5-(3-hydroxymethyl-bicyclo[1.1.1]pent-1-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-(4-isopropyl-phenyl)-methanol;

4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-methyl-piperidine-2,6-dione;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-2,2-difluoro-ethanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(3-methoxy-phenyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-(5-isopropyl-[1,2,4]oxadiazol-3-yl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[5-(6-methyl-pyrimidin-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-methanol;

(R)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-methyl-pyrrolidin-2-one;

(S)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-methyl-pyrrolidin-2-one;

(S)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-ethyl-pyrrolidin-2-one;

(R)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-ethyl-pyrrolidin-2-one;

(S)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-isopropyl-pyrrolidin-2-one;

(R)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-1-isopropyl-pyrrolidin-2-one;

1-[(S)-3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-ylmethyl)-pyrrolidin-1-yl]-ethanone;

(S)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-2-one;

(R)-4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-2-one;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(5-methyl-[1,2,4]oxadiazol-3-yl)-pyridin-3-yl]-methanol;

(R)-{5-[5-(1,1-Difluoro-ethyl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

4-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-yl)-tetrahydro-pyran-4-ol;

(R)-[5-(3-tert-Butoxymethyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-[5-(3-hydroxymethyl-[1,2,4]oxadiazol-5-yl)-pyridin-3-yl]-(4-isopropyl-phenyl)-methanol;

1-[4-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-yl)-piperazin-1-yl]-ethanone;

1-[3-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-ylmethyl)-azetidin-1-yl]-ethanone;

4-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-ylmethyl)-tetrahydro-pyran-4-ol;

[4-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-yl)-piperidin-1-yl]-[1,4]dioxan-2-yl-methanone;

1-[4-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-yl)-piperidin-1-yl]-2-methoxy-ethanone;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[3-(1-methanesulfonyl-piperidin-4-yl)-[1,2,4]oxadiazol-5-yl]-pyridin-3-yl}-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-{3-[1-(2-methoxy-ethanesulfonyl)-piperidin-4-yl]-[1,2,4]oxadiazol-5-yl}-pyridin-3-yl)-methanol;

1-[4-(5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-3-yl)-piperidin-1-yl]-2-hydroxy-ethanone;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-(5-[1,2,4]oxadiazol-3-yl-pyridin-3-yl)-methanol;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

2-(3-{5-[(R)-(4-Bromo-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-naphthalen-2-yl-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-[3-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-propan-2-ol;

2-[3-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-phenyl]-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-propan-2-ol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropoxy-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-[3-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(1,2,2,2-tetrafluoro-1-trifluoromethyl-ethyl)-phenyl]-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-propan-2-ol;

(R)-2-(3-(5-((1,3-dimethylazetidin-3-yl)(hydroxy)(4-(pentafluoro-λ 6 -sulfanyl)phenyl)methyl)pyridin-3-yl)-1,2,4-oxadiazol-5-yl)propan-2-ol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-(3-fluoro-4-isopropyl-phenyl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(4-tert-Butyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-Benzo[b]thiophen-5-yl-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-pentafluoroethyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-[3-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(1-methyl-cyclopropyl)-phenyl]-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-propan-2-ol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-3-methyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-trifluoromethoxy-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

1-[4-(3-{5-[(R)-(4-Bromo-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

2-[3-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-[4-(1-fluoro-1-methyl-ethyl)-phenyl]-hydroxy-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-propan-2-ol;

2-(3-{5-[(R)-[4-(1,1-Difluoro-ethyl)-phenyl]-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(4-Bicyclo[1.1.1]pent-1-yl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-{5-[5-(tetrahydro-pyran-4-yl)-[1,2,4]oxadiazol-3-yl]-pyridin-3-yl}-[4-(2,2,2-trifluoro-ethyl)-phenyl]-methanol;

2-[3-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-[4-(1,1-dimethyl-propyl)-phenyl]-hydroxy-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-propan-2-ol;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-(3-fluoro-4-isopropyl-phenyl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-{4-[3-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-trifluoromethoxy-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropoxy-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

2-(3-{5-[(R)-(3-Chloro-4-isopropyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(4-Cyclobutyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

1-[4-(3-{5-[(R)-(4-Cyclobutyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(3,5-Difluoro-4-isopropyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

2-(3-{5-[(R)-(3,5-Difluoro-4-isopropyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

1-[4-(3-{5-[(R)-(4-Cyclobutoxy-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

2-[3-(5-{(1,3-Dimethyl-azetidin-3-yl)-[4-(1-ethyl-propyl)-phenyl]-hydroxy-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-propan-2-ol;

1-{4-[3-(5-{(1,3-Dimethyl-azetidin-3-yl)-[4-(2,2-dimethyl-propyl)-phenyl]-hydroxy-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-ethanone;

2-[3-(5-{(1,3-Dimethyl-azetidin-3-yl)-[4-(2,2-dimethyl-propyl)-phenyl]-hydroxy-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-propan-2-ol;

1-{4-[3-(5-{(1,3-Dimethyl-azetidin-3-yl)-[4-(2,2-dimethyl-propyl)-phenyl]-hydroxy-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-ethanone;

1-{4-[3-(5-{(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(1-methyl-cyclopropyl)-phenyl]-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-ethanone;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-propyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(4-Cyclopropyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-ethyl-phenyl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(4-Butyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-trifluoromethyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-[3-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(2,2,2-trifluoro-ethyl)-phenyl]-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-propan-2-ol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isobutyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(4-Cyclobutoxy-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropenyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

1-{4-[3-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(2,2,2-trifluoro-ethyl)-phenyl]-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-propyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-Hydroxy-(1-isopropyl-3-methyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-[1-(2,2-Difluoro-ethyl)-3-methyl-azetidin-3-yl]-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-Hydroxy-[1-(2-hydroxy-ethyl)-3-methyl-azetidin-3-yl]-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(1-Cyclopropylmethyl-3-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-{4-[3-(5-{(R)-Hydroxy-(4-isopropyl-phenyl)-[1-(2-methoxy-ethyl)-3-methyl-azetidin-3-yl]-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-ethanone;

1-{4-[3-(5-{(R)-Hydroxy-(4-isopropyl-phenyl)-[3-methyl-1-(3,3,3-trifluoro-propyl)-azetidin-3-yl]-methyl}-pyridin-3-yl)-[1,2,4]oxadiazol-5-yl]-piperidin-1-yl}-ethanone;

1-[4-(3-{5-[(R)-Hydroxy-(4-isopropyl-phenyl)-(3-methyl-1-propyl-azetidin-3-yl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(1-Ethyl-3-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone;

1-(4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-piperidin-1-yl)-ethanone;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1,1-trifluoro-2-methyl-but-3-yn-2-ol;

Cyclopropanecarboxylic acid (3-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-prop-2-ynyl)-amide;

N-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-prop-2-ynyl)-isobutyramide;

N-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-prop-2-ynyl)-2-methoxy-acetamide;

3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-prop-2-ynyl)-oxazolidin-2-one;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-prop-2-ynyl)-pyrrolidin-2-one;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-prop-2-ynyl)-3-methyl-imidazolidin-2-one;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-prop-2-ynyl)-imidazolidin-2-one;

3-(1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-cyclopropyl)-oxazolidin-2-one;

1-((R)-2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-2-methyl-pyrrolidin-1-yl)-ethanone;

1-(4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-4-hydroxy-piperidin-1-yl)-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-hydroxy-1-methyl-prop-2-ynyl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-hydroxy-prop-2-ynyl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-prop-2-ynyl)-piperidin-1-yl]-ethanone;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1-hydroxy-prop-2-ynyl)-4-methyl-piperidin-1-yl]-ethanone;

1-(4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-4-methyl-piperidin-1-yl)-ethanone;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(1-methanesulfonyl-piperidin-4-ylethynyl)-pyridin-3-yl]-methanol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-4-methyl-piperidine-1-sulfonic acid methylamide;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(3-methanesulfonyl-3-methyl-but-1-ynyl)-pyridin-3-yl]-methanol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-cyclopropanesulfonic acid dimethylamide;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-cyclopropanesulfonic acid amide;

(R)-[5-(3-Cyclopropanesulfonyl-3-methyl-but-1-ynyl)-pyridin-3-yl]-(1,3-dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methanol;

(R)-3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-3-hydroxy-1-methyl-pyrrolidin-2-one;

(S)-3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-3-hydroxy-1-methyl-pyrrolidin-2-one;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-3,4-dihydro-2H-pyrano[3,2-b]pyridin-4-ol;

3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-ylethynyl}-3-hydroxy-1-methyl-1,3-dihydro-indol-2-one;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1H-indazol-3-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1-methyl-1H-indazol-3-yl)-but-3-yn-2-ol;

2-(1-Cyclopropyl-1H-pyrazol-3-yl)-4-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methyl-pyrimidin-4-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(5-methyl-pyrazin-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methyl-thiazol-5-yl)-but-3-yn-2-ol;

2-(6-Cyclopropyl-pyrimidin-4-yl)-4-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-but-3-yn-2-ol;

N-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-prop-2-ynyl)-acetamide;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methoxy-pyrimidin-4-yl)-but-3-yn-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methoxy-pyrimidin-4-yl)-but-3-yn-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methoxy-pyrimidin-4-yl)-but-3-yn-2-ol;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methoxy-pyrimidin-4-yl)-but-3-yn-2-ol;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2,6-dimethyl-pyrimidin-4-yl)-but-3-yn-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2,6-dimethyl-pyrimidin-4-yl)-but-3-yn-2-ol;

(S)-2-(2,6-Dimethoxy-pyrimidin-4-yl)-4-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-but-3-yn-2-ol;

(R)-2-(2,6-Dimethoxy-pyrimidin-4-yl)-4-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-but-3-yn-2-ol;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methoxy-6-methyl-pyrimidin-4-yl)-but-3-yn-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methoxy-6-methyl-pyrimidin-4-yl)-but-3-yn-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methoxy-2-methyl-pyrimidin-4-yl)-but-3-yn-2-ol;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methoxy-2-methyl-pyrimidin-4-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-trifluoromethyl-pyrimidin-4-yl)-but-3-yn-2-ol;

2-(6-Difluoromethyl-pyrimidin-4-yl)-4-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-but-3-yn-2-ol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-[5-(1-pyridin-2-yl-cyclopropylethynyl)-pyridin-3-yl]-methanol;

(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-isopropyl-phenyl)-{5-[1-(6-methyl-pyrimidin-4-yl)-cyclopropylethynyl]-pyridin-3-yl}-methanol;

1-[4-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-piperidin-1-yl]-ethanone;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1,1-trifluoro-2-methyl-butan-2-ol;

3-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-propyl)-oxazolidin-2-one;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-propyl)-pyrrolidin-2-one;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-propyl)-3-methyl-imidazolidin-2-one;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-1,1-dimethyl-propyl)-imidazolidin-2-one;

1-[(S)-2-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-ethyl)-2-methyl-pyrrolidin-1-yl]-ethanone;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1H-indazol-3-yl)-butan-2-ol;

2-(1-Cyclopropyl-1H-pyrazol-3-yl)-4-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methyl-pyrimidin-4-yl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(5-methyl-pyrazin-2-yl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-methyl-thiazol-5-yl)-butan-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(3-methyl-isoxazol-5-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1-methyl-1H-imidazol-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(5-methyl-thiophen-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(1-methyl-1H-pyrrol-2-yl)-but-3-yn-2-ol;

(R)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-trifluoromethyl-pyrimidin-4-yl)-but-3-yn-2-ol;

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(2-trifluoromethyl-pyrimidin-4-yl)-but-3-yn-2-ol;

4-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(1-trifluoromethyl-cyclopropyl)-phenyl]-methyl}-pyridin-3-yl)-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

4-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(1-methyl-cyclopropyl)-phenyl]-methyl}-pyridin-3-yl)-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-trifluoromethyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-(4-ethyl-phenyl)-hydroxy-methyl]-pyridin-3-yl}-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-(4-tert-Butyl-phenyl)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-methyl]-pyridin-3-yl}-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-(3-Ethyl-1-methyl-azetidin-3-yl)-hydroxy-(4-trifluoromethoxy-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

4-(5-{(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-[4-(2,2,2-trifluoro-ethyl)-phenyl]-methyl}-pyridin-3-yl)-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

4-{5-[(S)-(3-Fluoro-1-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

1-(4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-ylethynyl}-piperidin-1-yl)-ethanone;

N-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-1,1-dimethyl-prop-2-ynyl)-acetamide;

1-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-1,1-dimethyl-prop-2-ynyl)-pyrrolidin-2-one;

4-{5-[(R)-Hydroxy-(1-isopropyl-3-methyl-azetidin-3-yl)-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-Hydroxy-[1-(2-hydroxy-ethyl)-3-methyl-azetidin-3-yl]-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

4-{5-[(R)-[1-(2,2-Difluoro-ethyl)-3-methyl-azetidin-3-yl]-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

1-(4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yloxymethyl}-piperidin-1-yl)-ethanone;

4-{5-[(R)-(1-Cyclopropyl-3-methyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyridin-2-yl)-but-3-yn-2-ol;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-(2-isopropyl-pyrimidin-4-yl)-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-(2-methyl-thiazol-5-yl)-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-(6-methyl-pyridin-3-yl)-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-(6-isopropyl-pyridin-2-yl)-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-(6-trifluoromethyl-pyridin-3-yl)-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-(1-methyl-1H-pyrazol-4-yl)-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-(1,3-dimethyl-1H-pyrazol-4-yl)-pyrrolidin-2-one;

4-(1-Difluoromethyl-1H-pyrazol-4-yl)-1-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrrolidin-2-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-4-(2-methyl-2H-[1,2,3]triazol-4-yl)-pyrrolidin-2-one;

4-(1-Acetyl-piperidin-4-yl)-1-{5-[(R)-(1,3-dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-pyrrolidin-2-one;

5-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-hexahydro-furo[2,3-c]pyrrol-4-one;

1-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridazin-3-yl}-4-(6-isopropyl-pyridin-2-yl)-pyrrolidin-2-one;

1-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl)-ethanone;

1-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-7,8-dihydro-5H-[1,6]naphthyridin-6-yl)-ethanone;

1-[4-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrimidin-5-yl)-piperidin-1-yl]-ethanone; or

1-[4-(2-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-pyrimidin-4-yl)-piperidin-1-yl]-ethanone;

or a pharmaceutically acceptable salt thereof.

11 . A compound according to claim 1 which is:

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol;

1-[4-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-ethanone; or

(S)-4-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-2-(6-methyl-pyrimidin-4-yl)-but-3-yn-2-ol;

or a pharmaceutically acceptable salt thereof.

12 . A compound which is:

2-(3-{5-[(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4]oxadiazol-5-yl)-propan-2-ol; or a pharmaceutically acceptable salt thereof.

13 . A pharmaceutical composition comprising a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier.

14 . A method for the prevention or treatment of an inflammatory/autoimmune disease/disorder, or cancer; said method comprising administering to a subject a pharmaceutically active amount of a compound according to claim 1 , or a pharmaceutically acceptable salt thereof, either alone or in combination with another pharmacologically active compounds and/or therapy.

15 . A pharmaceutical composition comprising a compound according to claim 10 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier.

16 . A method for the prevention or treatment of an inflammatory/autoimmune disease/disorder, or cancer; said method comprising administering to a subject a pharmaceutically active amount of a compound according to claim 10 , or a pharmaceutically acceptable salt thereof, either alone or in combination with another pharmacologically active compound and/or therapy.

17 . A pharmaceutical composition comprising a compound according to claim 11 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier.

18 . A method for the prevention or treatment of an inflammatory/autoimmune disease/disorder, or cancer; said method comprising administering to a subject a pharmaceutically active amount of a compound according to claim 11 , or a pharmaceutically acceptable salt thereof, either alone or in combination with another pharmacologically active compound and/or therapy.

19 . A pharmaceutical composition comprising the compound according to claim 12 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier.

20 . A method for the prevention or treatment of an inflammatory/autoimmune disease/disorder, or cancer; said method comprising administering to a subject a pharmaceutically active amount of the compound according to claim 12 , or a pharmaceutically acceptable salt thereof, either alone or in combination with another pharmacologically active compound and/or therapy.

21 . A compound according to claim 1 , wherein A represents pyridin-3-yl, wherein said pyridin-3-yl is mono-substituted in meta-position with respect to the point of attachment of said pyridin-3-yl to the rest of the molecule, wherein the substituent is 5-(hydroxy-methyl)-1,2,4-oxadiazol-3-yl, 5-(1-hydroxy-1-methyl-ethyl)-1,2,4-oxadiazol-3-yl, 5-(2-hydroxy-2-methyl-propyl)-1,2,4-oxadiazol-3-yl, or 5-(2-hydroxy-1,1-dimethyl-ethyl)-1,2,4-oxadiazol-3-yl; B represents 4-propyl-phenyl, 4-isopropyl-phenyl, 4-isobutyl-phenyl, 4-tert-butyl-phenyl, 3-fluoro-4-isopropyl-phenyl, 3,5-difluoro-4-isopropyl-phenyl, 4-cyclopropyl-phenyl, 4-trifluoromethyl-phenyl, 4-trifluoromethoxy-phenyl, 4-(2,2,2-trifluoro-ethyl)-phenyl, 4-cyclobutyl-phenyl, or 4-(1-trifluoromethyl-cyclopropyl)-phenyl; R 1 represents methyl; and R 2 represents methyl;

or a pharmaceutically acceptable salt thereof.

22 . The compound according to claim 12 , wherein said compound is in free form.

23 . A compound which is 2-(3-{5- [(R)-(1,3-Dimethyl-azetidin-3-yl)-hydroxy-(4-isopropyl-phenyl)-methyl]-pyridin-3-yl}-[1,2,4] oxadiazol-5-yl)-propan-2-ol in pharmaceutically acceptable salt form.

24 . The method according to claim 20 , for the treatment of an inflammatory/autoimmune disease/disorder, said method comprising administering to a subject a pharmaceutically active amount of the compound according to claim 12 , or a pharmaceutically acceptable salt thereof.

25 . The method according to claim 24 , wherein the inflammatory/autoimmune disease/disorder is selected from rheumatoid arthritis; ankylosing spondylitis; spondyloarthritis; psoriasis; psoriatic arthritis; inflammatory skin disorders; irritable bowel disease; inflammatory bowel disease; dry eye disease; multiple sclerosis; systemic lupus erythematosus; Sjögren's disease; autoimmune hepatitis; Primary Sclerosing Cholangitis; autoimmune keratitis; filamentary keratitis; autoimmune uveitis; allergic conjunctivitis; asthma; allergic disease of the gastrointestinal tract; type 1 diabetes (T1D); endometriosis; meibomian gland dysfunction; and graft-versus host disease.

26 . The method according to claim 24 , wherein the inflammatory/autoimmune disease/disorder is selected from psoriasis; psoriatic arthritis; rheumatoid arthritis; ankylosing spondylitis; spondyloarthritis;

inflammatory skin disorders; Crohn's disease; ulcerative colitis; irritable bowel disease; dry eye disease;

multiple sclerosis; systemic lupus erythematosus; Sjögren's disease; autoimmune hepatitis; and Primary Sclerosing Cholangitis.

27 . The method according to claim 24 , wherein the inflammatory/autoimmune disease/disorder is selected from psoriasis; psoriatic arthritis; rheumatoid arthritis; ankylosing spondylitis; spondyloarthritis; Crohn's disease; ulcerative colitis; and Primary Sclerosing Cholangitis.

28 . The method according to claim 20 , for the treatment of cancer; said method comprising administering to a subject a pharmaceutically active amount of the compound according to claim 27 , or a pharmaceutically acceptable salt thereof, either alone or in combination with another pharmacologically active compound and/or therapy.

29 . The method according to claim 28 , for the treatment of cancer; said method comprising administering to a subject a pharmaceutically active amount of the compound according to claim 27 , or a pharmaceutically acceptable salt thereof, either alone or in combination with another pharmacologically active compound and/or therapy, wherein the cancer is selected from lymphoma; brain cancer; breast cancer; colorectal cancer; hepatocarcinoma; renal cell carcinoma; lung cancer; gastric cancer; melanoma; bladder cancer; head and neck cancer; Hodgkin's lymphoma; cervical cancer; endometrial cancer; colon cancer; gastrointestinal stromal tumors; pancreatic cancer; prostatic cancer; leukemia; ovarian cancer; oesophageal carcinomas; mesothelioma; neuroblastoma; sarcoma; astrocytoma; myeloma; urothelial cancer; MSI-H or dMMR cancer; rectal cancer; laryngeal cancer; salivary adenocarcinoma; multiple myeloma; cholangiocarcinoma; oral squamous cell carcinoma; thyroid cancer; and esophagogastric junction cancer.

30 . The method according to claim 28 , for the treatment of cancer; said method comprising administering to a subject a pharmaceutically active amount of the compound according to claim 27 , or a pharmaceutically acceptable salt thereof, either alone or in combination with another pharmacologically active compound and/or therapy, wherein the cancer is selected from lymphoma; brain cancer; breast cancer; colorectal cancer; hepatocarcinoma; renal cell carcinoma; lung cancer; and gastric cancer.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Jun 25, 2026
From: IDORSIA PHARMACEUTICALS LTD
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 076038/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2022
From: ALLEMANN, OLIVER; CAROFF, EVA; CHAVANTON-ARPEL, ALEXIA; CROXFORD, ANDREW; HUBLER, FRANCIS; JACOB, LOIC; MEYER, EMMANUEL; RICHARD-BILDSTEIN, SYLVIA
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 061587/0808 →
Priority Claims (1)
WO PCT/EP2020/062103 · Apr 30, 2020 · international
Continuity (1)
Related Publication 20230174514A1 · Jun 8, 2023
References Cited (161)
US 3458635A · Lunsford et al. · 1969 [cited by applicant]
US 3479370A · Lunsford et al. · 1969 [cited by applicant]
US 3489769A · Helsley et al. · 1970 [cited by applicant]
US 3499002A · Helsley et al. · 1970 [cited by applicant]
US 3542807A · Lunsford et al. · 1970 [cited by applicant]
US 3651085A · Lunsford et al. · 1972 [cited by applicant]
US 20030119806A1 · Lindell · 2003 [cited by examiner]
US 20140296254A1 · Musicki et al. · 2014 [cited by applicant]
US 20140309208A1 · Musicki et al. · 2014 [cited by applicant]
US 20150105366A1 · Leonard et al. · 2015 [cited by applicant]
US 20250011313A1 · Alleman et al. · 2025 [cited by applicant]
US 20250042881A1 · Alleman et al. · 2025 [cited by applicant]
CN 103588697A · 2014 [cited by applicant]
GB 1304650A · 1973 [cited by applicant]
WO WO9113359A1 · 1991 [cited by applicant]
WO WO1993020063A1 · 1993 [cited by applicant]
WO WO9943664A1 · 1999 [cited by applicant]
WO WO03022808A1 · 2003 [cited by applicant]
WO WO2006136830A1 · 2006 [cited by applicant]
WO WO2007022351A2 · 2007 [cited by applicant]
WO WO2008103426A1 · 2008 [cited by applicant]
WO WO2010131145A1 · 2010 [cited by applicant]
WO WO2013061004A1 · 2013 [cited by applicant]
WO WO2013061005A1 · 2013 [cited by applicant]
WO WO2014062658A1 · 2014 [cited by applicant]
WO WO2014075580A1 · 2014 [cited by applicant]
WO WO2015057205A1 · 2015 [cited by applicant]
WO WO2015057626A1 · 2015 [cited by applicant]
WO WO2015084842A1 · 2015 [cited by applicant]
WO WO2017087607A1 · 2017 [cited by applicant]
WO WO2019036374A1 · 2019 [cited by applicant]
WO WO2019105915A1 · 2019 [cited by applicant]
WO WO2019136370A2 · 2019 [cited by applicant]
WO WO2019147862A1 · 2019 [cited by applicant]
WO WO2020058869A1 · 2020 [cited by applicant]
WO WO2023057548A1 · 2023 [cited by applicant]
WO WO2023072924A1 · 2023 [cited by applicant]
WO WO2023073082A1 · 2023 [cited by applicant]
WO WO2024121138A1 · 2024 [cited by applicant]
Abe, F. et al., “Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma,” Oncotarget, 2017, 8 (5), 7572-7585. [cited by applicant]
Abraham, M. et al., “Natural and induce immunization against CCL20 ameliorate experimental autoimmune encephalitis and may confer protection against multiple sclerosis,” Clinical Immunology, 2017, 183, 316-324. [cited by applicant]
Acosta-Rodriguez, E. et al., “Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells,” Nature Immunology, 2007, 8 (6) 639-646. [cited by applicant]
Baeten, D. et al., “Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis,” The New England Journal of Medicine, 2015, 373 (26), 2534-2548. [cited by applicant]
Blokland, S. et al., “Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their… [cited by applicant]
Bonelli, M. et al., “CCR6 controls autoimmune but not innate immunity-driven experimental arthritis,” Journal of Cellular and Molecular Medicine, 2018, 22, 5278-5285. [cited by applicant]
Buhl, T. et al., “Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways,” Journal of Investigative Dermatology, 2015, 135, 2198-2208. [cited by applicant]
Campbell, J. et al.,“IL-17-Secreting γδ T Cells Are Completely Dependent upon. CCR6 for Homing to Inflamed Skin,” The Journal of Immunology, 2017, 199, 3129-3136. [cited by applicant]
Campell, J. et al., “Efficacy of Chemokine Receptor Inhibition in Treating IL-36α-Induced Psoriasiform Inflammation,” The Journal of Immunology, 2019, 202, 1687-1692. [cited by applicant]
Castro, G. et al., “RORγt and RORα signature genes in human Th17 cells,” PLoS ONE, 2017, 12(8): e0181868, 22 pages, https://doi.org/10.1371/journal.pone.0181868. [cited by applicant]
Chabaud, M. et al., “Enhancing Effect of IL-1, IL-17, and TNF-α on Macrophage Inflammatory Protein-3α Production in Rheumatoid Arthritis: Regulation by Soluble Receptors and Th2 Cytokines,” The Journal of Immunology, 20… [cited by applicant]
Chang, H., et al., “CCR6 is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer,” Cancer Research and Treatment, 2018, 50 (4), 1203-1213. [cited by applicant]
Chen, W. et al., “CCL20 Triggered by Chemotherapy Hinders the Therapeutic Efficacy of Breast Cancer,” PLoS Biology, 2018, 16(7):e2005869, 27 pages, https://doi.org/10.1371/journal.pbio.2005869. [cited by applicant]
Chevrel, G. et al., “Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor α soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3x and incr… [cited by applicant]
Chew, V. et al., “Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses,” PNAS Early Edition, 2017, 10 pages, www.pnas.org/cgi/doi/10.1073/… [cited by applicant]
Cohen, S., “Rituximab for Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy,” Arthritis & Rheumatism, 2006, 54 (9), 2793-2806. [cited by applicant]
Cook, D. et al., “CCR6 Mediates Dendritic Cell Localization, Lymphocyte Homeostasis, and Immune Responses in Mucosal Tissue,” Immunity, 2000, 12, 495-503. [cited by applicant]
Coperchini, F. et al., “TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer,” Tumor Biol… [cited by applicant]
Cua, D. et al., “Innate IL-17-producing cells: the sentinels of the immune system,” Nature Reviews, Immunology, 2010, 10, 479-489 and corrigendum. [cited by applicant]
Ding, X., et al., “High Expression of CCL20 is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma after Curative Resection,” Journal of Gastrointestinal Surgery, 2012, 16, 828-836. [cited by applicant]
Dohlman, T. et al., “The CCR6/CCL20 Axis Mediates Th17 Cell Migration to the Ocular Surface in Dry Eye Disease,” Immunology and Microbiology, 2013, 54 (6), 4081-4091. [cited by applicant]
Dolcino, M. et al., “Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis,” PLoS ONE, 2015, 10(6): e0128262, 33 pages, doi: 10.1371/journal.pone.0128262. [cited by applicant]
El Sharkawi, F. et al., “The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt,” Gene, 2019, 685, 164-169. [cited by applicant]
Elhofy, A. et al., “Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis,” NIH Public Access, Author Manuscript, Available in PMC 2010, 19 pages, doi: 10.1016/j.jneuroim.2009.05.011,… [cited by applicant]
Ghadjar, P. et al., “Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer,” Journal of Cancer Research and Clinical Oncology, 2008, 134 (11), 1181-1189. [cited by applicant]
Giuliani, N. et al., “CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3α and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions,” Cancer Research, 2008, 68 (1… [cited by applicant]
Greaves, D. et al., “CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells,” Journal of Experimental Medicine, 1997, 186 (6), 837-844. [cited by applicant]
Greene, T. et al., Eds., Protective Groups in Organic Synthesis, Wiley-Interscience, 1999. [cited by applicant]
Guo, W. et al., “DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway,” Oncology Reports, 2019, 15 pages, doi: 10.3982/or.2019.7221. [cited by applicant]
Harasawa, H. et al., “Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma,” Leukemia & Lymphoma, 2006, 47 (10), 2163-2173. [cited by applicant]
Harper, E. et al., “Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis,” NIH Public Access, Author Manuscript, Available in PMC 2010, 16 pages, doi: … [cited by applicant]
Hashikawa, K. et al., “Microarray analysis of gene expression by microdissected epidermis and dermis in mycosis fungoides and adult T-cell leukemia/lymphoma,” Internal Journal of Oncology, 2014, 45, 1200-1208. [cited by applicant]
Hattori, T. et al., “Gene Expression Profiling of IL-17A-Treated Synovial Fibroblasts from the Human Temporomandibular Joint,” Mediators of Inflammation, 2015, Article ID 436067, 12 pages, http://dx.doi.org/10.1155/2015… [cited by applicant]
He, H. et al., “CCR6 [cited by applicant]
Hedrick, M et al., “CCR6 is required for IL-23-induced psoriasis-like inflammation in mice,” The Journal of Clinical Investigation, 2009, 119 (8), 2317-2329. [cited by applicant]
Hedrick, M. et al., “CCR6 as a possible therapeutic target in psoriasis,” NIH Public Access, Author Manuscript, Available in PMC 2013, 19 pages, doi: 10.1517/14728222.2010.504716, face of article states: Published in fi… [cited by applicant]
Hirota, K. et al., “Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model,” The Journal of Experimental Medicine, 2007, 204 (12), 2803-2812. [cited by applicant]
Ivanov, I. et al., “The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17 [cited by applicant]
Jin, P. et al., “Astrocyte-derived CCL2-reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-γB signaling pathway,” Oncogene, 2018, 37, 3070-3087. [cited by applicant]
Kang, M. et al., “Interleukin-17 in Various Ocular Surface Inflammatory Diseases,” Journal of Korean Medical Science, 2011, 26, 938-944. [cited by applicant]
Kenna, K. et al., “Enrichment of Circulating Interleukin-17-Secreting Interleukin-23 Receptor-Positive γ/δ T Cells in Patients With Active Ankylosing Spondylitis,” Arthritis & Rheumatism, 2012, 64 (5), 1420-1429. [cited by applicant]
Kirshberg, S. et al. “Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease Progression,” PLoS ONE, 2011, 6(9): e24856, 10 pages, doi.10.1371/journal.pone.0024856. [cited by applicant]
Kleeff, J. et al., “Detection and localization of MIP-3αLARC/EXODUS, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer,” International Journal of Cancer, 1999, 8, 650-657. [cited by applicant]
Kohler, R. et al., “A Role for Macrophage Inflammatory Protein-3α/CC Chemokine Ligand 20 in Immune Priming During T Cell-Mediated Inflammation of the Central Nervous System,” The Journal of Immunology, 2003, 170, 6298-6… [cited by applicant]
Kwon, J. et al., “Colonic epithelial cells are a major site of macrophage inflammatory protein 3α(MIP-3α) production in normal colon and inflammatory bowel disease,” Gut, 2002, 51, 818-826. [cited by applicant]
Lee, A. et al., “Expression of CCR6 on B cells in systemic lupus erythematosus patients,” Clinical Rheumatology, 2017, 36, 1453-1456. [cited by applicant]
Lee, H-J. et al., “Increased Expression of MIP-3α/CCL20 in Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis and Its Down-regulation by Sulfasalazine and Glucocorticoid Treatment,” Inflammatory Bo… [cited by applicant]
Lee, J-J. et al., “Enrichment of Human CCR6 [cited by applicant]
Lee, S. et al., “Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis,” Scientific Reports, 2017, 7: 9610, 13 pages, doi: 10.1038/s41598-017-09040-4. [cited by applicant]
Leipe, J., et al., “Role of Th17 Cells in Human Autoimmune Arthritis,” Arthritis & Rheumatism, 2010, 62 (10), 2876-2885. [cited by applicant]
Liu, J. et al., “Tumor-Associated Macrophages Recruit CCR6 [cited by applicant]
Liu, J. et al., “CCR6 is a Prognostic Marker for Overall Survival in Patients with Colorectal Cancer, and Its Overexpression Enhances Metastasis In Vivo,” PLoS ONE, 2014, 9(6): e101137, 13 pages, doi: 10.1371/journal.po… [cited by applicant]
Liu, W. et al., “Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis,” Cancer Letters, 2020, 473, 59-69. [cited by applicant]
Lu, E et al., “CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway,” Biomedicine & Pharmacotherapy, 2017, 85, 486-492. [cited by applicant]
Mabuchi, T. et al., “Chemokine receptors in the pathogenesis and therapy of psoriasis,” Journal of Dermatological Science, 2012, 65, 4-11. [cited by applicant]
Matsui, T. et al., “Selective recruitment of CCR6-expressing cells by increased production of MIP-3α in rheumatoid arthritis,” Clinical & Experimental Immunology, 2001, 125, 155-161. [cited by applicant]
Maung, H. et al., “Common transcriptional programs and the role of chemokine (C-C motif) ligand 20 ( [cited by applicant]
Mays, A. et al., “Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma,” Anticancer Research, 2016, 36, 4013-4018. [cited by applicant]
Meares, G. et al., “Regulation of CCL20 Expression in Astrocytes by IL-6 and IL-17,” Gila, 2012, 60, 771-781. [cited by applicant]
Meissner, A. et al., “CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress,” Blood, 2003, 102 (8), 2724-2727. [cited by applicant]
Melis, L. et al., “Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis,” Annals of Rheumatic Diseases, 2010, 69, 618-623. [cited by applicant]
Miyagaki, T. et al., “IL-22, but Not IL-17, Dominant Environment in Cutaneous T-cell Lymphoma,” Clinical Cancer Research, 2011, 17 (24), 7529-7538. [cited by applicant]
Möller, C et al., “Expression and function of chemokine receptors in human multiple myeloma,” Leukemia, 2003, 17, 203-210. [cited by applicant]
Montresor, C. et al., “Chemokines and the signaling modules regulating integrin affinity,” Frontiers in Immunology, 2012, 3, Article 127, 10 pages, doi: 10.3389.fimmu.2012.00127. [cited by applicant]
Mony, J. et al., “Chemokine receptor expression by inflammatory T cells in EAE,” Frontiers in Cellular Neuroscience, 2014, 8, Article 187, 9 pages, doi: 10.3389/fncel.2014.00187. [cited by applicant]
Moody, S. et al., “Novel [cited by applicant]
Mrizak, D. et al., “Effect of Nasopharyngeal Carcinoma-Derived Exosomes on Human Regulatory T Cells,” Journal of the National Cancer Institute, 2015, 107 (1): dju363, 13 pages, doi: 10.1093/jnci/dju363. [cited by applicant]
Nandi, B. et al., “CCR6, the Sole Receptor for the Chemokine CCL20, Promotes Spontaneous Intestinal Tumorigenesis,” PLoS ONE, 2014, 9(5): e97566, 10 pages, doi: 10.1371/journal.pone.0097566. [cited by applicant]
Nistala, K., et al., “Interleukin-17-Producing T Cells Are Enriched in the Joints of Children With Arthritis, but Have a Reciprocal Relationship to Regulatory T Cell Numbers,” Arthritis & Rheumatism, 2008, 58 (3), 875-8… [cited by applicant]
Papp, K. et al., “Brodalumab, an Anti-Interleukin-17-receptor Antibody for Psoriasis,” The New England Journal of Medicine, 2012, 336 (13), 1181-1189. [cited by applicant]
Paul, C. et al., “Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (Juncture),” Journal of European Academy of Dermatology and Venereology, 20… [cited by applicant]
Ranasingh, R. et al., “Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer,” Medicina, 2018, 54, 88, 12 pages, doi: 10.3390/medicina54050088. [cited by applicant]
Reboldi, A. et al., “C-C chemokine receptor 6-regulated entry of T [cited by applicant]
Reboldi, A. et al., “IgA production requires B cell interaction with subepithelial dendritic cells in Peyer's patches,” HHS Public Access, Author Manuscript, Available in PMC 2016, 25 pages, doi: 10.1126/science.aaf4822… [cited by applicant]
Reich, K. et al., “Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (Eclipse): results from a phase 3, randomised controlled trial,” Lancet, 2019, 394, 831-839. [cited by applicant]
Remington, The Science and Practice of Pharmacy, 21st Edition, 2005, Part 5, “Pharmaceutical Manufacturing,” published by Lippincott Williams & Wilkins. [cited by applicant]
Robert, R., et al., “Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mic,” JCI Insight, 2017, 2(15):394821, 17 pages, https://doi.org/10.1172/jci.insight.94821. [cited by applicant]
Rubie, C. et al., “Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases,” World Journal of Gastroenterology, 2006, 12 (41), 6627- 6633. [cited by applicant]
Rubie, C. et al., “CCL20/CCR6 expression in profile in pancreatic cancer,” Journal of Translational Medicine, 2010, 8:45, 8 pages, doi: 10.1186/1479-5876-8-45. [cited by applicant]
Schutyser, E. et al., “The CC chemokine CCL20 and its receptor CCR6,” Cytokine & Growth Factor Reviews, 2003, 14, 409-426. [cited by applicant]
Shen, H. et al., “Frequency and Phenotype of Peripheral Blood Th17 Cells in Ankylosing Spondylitis and Rheumatoid Arthritis,” Arthritis & Rheumatism, 2009, 60 (6), 1647-1656. [cited by applicant]
Singh, S. et al., “Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR6,” The Journal of Immunology, 2008, 180, 214-221. [cited by applicant]
Skepner, J., et al., “Pharmacologic Inhibition of RORγt Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo,” The Journal of Immunology, 2014, 192, 2564-2575. [cited by applicant]
Skovdahl, H. et al., “Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells,” PLoS ONE, 2015, 10(11): e0… [cited by applicant]
Stahl, P. et al., Eds., Handbook of Pharmaceutical Salts, Properties, Selection, and Use, Wiley-VCH, 2008. [cited by applicant]
Suan, D. et al., “CCR6 Defines Memory B Cell Precursors in Mouse and Human Germinal Centers, Revealing Light-Zone Location and Predominant Low Antigen Affinity,” Immunity, 2017, 47, 1142-1153 and e1-e4. [cited by applicant]
Sucur, A., et al., “Combined manual and automated immunophenotypisation identified disease-specific peripheral blood immune subpopulations in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis,” Clinic… [cited by applicant]
Tanis, V. et al., “3-Substituted Quinolines as RORγt Inverse Agonists,” Bioorganic & Medicinal Chemistry Letters, 2019, 29, 1463-1470. [cited by applicant]
Tawaraishi, T. et al., “Identification of a novel series of potent and elective CCR6 inhibitors as biological probes,” Bioorganic & Medicinal Chemistry Letters, 2018, 28, 3067-3072. [cited by applicant]
Tsaur, I. et al., “CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study,” Cancer Research Treatment, 2015, 47 (2), 306-312. [cited by applicant]
Uchida, K. et al., “The Increased Expression of CCL20 and CCR6 in Rectal Mucosa Correlated to Severe Inflammation in Pediatric Ulcerative Colitis,” Gastroenterology Research and Practice, 2015, Article ID 856532, 6 page… [cited by applicant]
Van Hamburg, J. et al., “Th17 Cells, but Not Th1 Cells, From Patients With Early Rheumatoid Arthritis Are Potent Inducers of Matrix Metalloproteinases and Proinflammatory Cytokines Upon Synovial Fibroblast Interaction, … [cited by applicant]
Van Langelaar, J. et al., “T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention,” Brain, 2018, 141, 1334-1349. [cited by applicant]
Varona, R. et al., “CCR6 has a non-redundant role in the development of inflammatory bowel disease,” European Journal of Immunology, 2003, 33, 2937-2946. [cited by applicant]
Wallace, A. et al., “Chemokine (C-C) motif ligand 20 is regulated by PGF [cited by applicant]
Wang, L. et al., “Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas,” Medical Oncology, 2012, 29, 3491-3497. [cited by applicant]
Yu, S. et al., “Is CCR6 Required for the Development of Psoriasiform Dermatitis in Mice?” HHS Public Access, Author Manuscript, Available in PMC 2019, 6 pages, doi:10.1016/j.jid.2018.07.036, face of article states: Publ… [cited by applicant]
Zhang, C., et al., “The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients,” Biomedicine & Pharmacotherapy, 2015, 69, 242-248. [cited by applicant]
Zhang, X-P. et al., “Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma,” Oncology Letters, 2017, 14, 8183-8189. [cited by applicant]
Zhao, X. et al., “Synergistic association of FOXP3 [cited by applicant]
Al-Mossawi, M. et al., “Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis,” Nature Communications, 2017, 8:1510, 11 pages, doi: 10.1038/s41467-017-01771-2. [cited by applicant]
Dellacasagrande, J. et al., “Liver Metastasis of Cancer Racilitated by Chemokine Receptor CCR6,” Scandinavian Journal of Immunology, 2003, 57, 534-544. [cited by applicant]
Elgueta, R. et al., “CCR6-Dependent Positioning of Memory B Cells Is Essential for Their Ability To Mount a Recall Response to Antigen,” The Journal of Immunology, 2015, 194 (2), 505-513. [cited by applicant]
Getschman, A. et al., “Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model,” PNAS, 2017, 117 (47), 12460-12465. [cited by applicant]
Ikeda, S. et al., “Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma,” Oncotarget, 2016, 7 (12), 13563-13574. [cited by applicant]
Ito, M. et al., “MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma,” Blood, 2014, 123 (10), 1499-1511. [cited by applicant]
Iwamoto, S. et al., “TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression,” Clinical Immunology, 2013, 146, 15-25. [cited by applicant]
Kadomoto, S. et al., “Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis,” Cancers, 2020, 12, 89, 13 pages, doi: 10.3390/cancers12010089. [cited by applicant]
Lin, Y-L. et al., “CCR6 Deficiency Impairs IgA Production and Dysregulates Antimicrobial Peptide Production, Altering the Intestinal Flora,” Frontiers in Immunology, 2017, 8:805, 20 pages, doi: 10.3389/fimmu.2017.00805. [cited by applicant]
Marsigliante, S. et al., “Paracrine CCL20 Loop Induces Epithelial-Mesenchymal Transition In Breast Epithelial Cells,” Molecular Carcinogenesis, 2016, 55, 1175-1186. [cited by applicant]
Wang, G-Z. et al., “Tobacco smoke induces production of chemokine CCL20 to promote lung cancer,” Cancer Letters, 2015, 363, 60-70. [cited by applicant]
Wang, L-X. et al., “Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma,” PLoS One, 2018, 13(1): e0190447, 16 pages, http://doi.org/10.1371/journal.pone.0190447. [cited by applicant]
Wouters, J. et al., Eds., Pharmaceutical Salts and Co-crystals, RSC Publishing, 2012. [cited by applicant]
Wu, Q. et al., “Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver C… [cited by applicant]
Zhong, W. et al., “CCR6 [cited by applicant]
Zhu, C. et al., “CCR6 promotes tumor angiogenesis via the AKT/NF-kB/VEGF pathway in colorectal cancer,” BBA—Molecular Basis of Disease, 2018, 1864, 387-397. [cited by applicant]
U.S. Appl. No. 18/704,588, filed Apr. 25, 2024 (371(c) Date), Alleman et al. [cited by applicant]
U.S. Appl. No. 18/705,346, filed Apr. 26, 2024 (371(c) Date), Alleman et al. [cited by applicant]
U.S. Appl. No. 19/136,271, filed Jun. 5, 2025 (371(c) Date), Fleischer et al. [cited by applicant]
Kulig, P. et al., “Efficacy of IDOR-1117-2520, a novel, orally available CCR6 antagonist in preclinical models of skin dermatitis,” British Journal of Pharmacology, 2025, 24 pages, DOI: 10.1111/bph.70025. [cited by applicant]
Meyer, E. et al., “Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases,” Journal of Medicinal Chemistry, 2024, 67, 8077-8098. [cited by applicant]
Meyer, E., “Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases,” RICT Conference Presentation, 2024, 30 pages. [cited by applicant]